Stock Report

Download full stock data and analysis for free Last Updated: 06-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Biogen Pharmachem Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 531752

₹0.26

₹0.00 (0.00%)

As on 06-Nov-2026IST

Market cap

info icon

₹27 Cr

Revenue (TTM)

info icon

₹1 Cr

P/E Ratio

info icon

47

P/B Ratio

info icon

0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -64.73 11.18 -25.98
EBIT -111.76 93.26 -115.24 -217.71 -177.34
Net Profit 16.29 152.34 -64.73 11.18 -25.98
EPS 14.29 151.06 -71.79 -30.24 18.13
Book Value -- -- -0.53 1.27 0.17
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info ---49.71-23.80----
Net Margin info ---0.3531.53----
Return on equity info 1.260.170.59-0.523.48
Return on Capital info 1.320.20---0.363.48
Return on Assets info 1.300.190.59-0.393.46
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
-0.36
3.48
0.84
-0.02
Peer Median
--
3.50
10.64
0.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

0.59

Lower than Peers by 12.75

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.59
-0.52
3.48
0.84
-0.02
Peer Median
13.33
1.79
26.31
0.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.59

Lower than Peers by 2.88

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.59
-0.39
3.46
0.83
-0.02
Peer Median
3.46
1.68
2.48
0.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-23.80

Lower than Peers by 79.91

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-23.80
--
--
--
-0.61
Peer Median
56.11
37.67
54.90
27.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

31.53

Higher than Peers by 16.60

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
31.53
-24.44
81.07
49.90
-0.35
Peer Median
14.93
15.34
15.32
22.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
-0.35
Peer Median
--
--
--
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-64.73

Lower than Peers by 79.76

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-64.73
--
--
-100.00
52.48
Peer Median
15.03
48.89
42.20
46.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-115.24

Lower than Peers by 133.08

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-115.24
-225.55
1.40
-2,907.89
99.05
Peer Median
17.84
11.00
51.15
16.35
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-64.73

Lower than Peers by 81.74

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-64.73
-115.16
323.86
5,396.51
99.46
Peer Median
17.01
-21.65
36.20
63.86
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-71.79

Lower than Peers by 86.00

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-71.79
-115.20
322.86
7,100.00
99.59
Peer Median
14.21
-21.88
36.23
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
-0.52
3.54
0.84
-0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
0.01
1.40
0.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

18.89

Higher than Peers by 16.24

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
18.89
29.65
0.30
0.65
2.37
Peer Median
2.66
3.35
1.02
3.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

18.89

Higher than Peers by 16.24

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
18.89
29.65
0.30
0.65
2.37
Peer Median
2.66
3.66
5.14
4.69
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
4,556.00
-42.00
Peer Median
137.50
7.04
1.66
4.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
5.18
31.95
18.14
32.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.22

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.01
--
--
--
0.05
Peer Median
0.23
0.15
0.63
0.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

47.04

Higher than Peers by 19.43

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
47.04
--
35.81
84.29
--
Peer Median
27.61
80.10
52.43
85.70
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.24

Lower than Peers by 3.27

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.24
1.11
1.22
0.71
1.69
Peer Median
3.50
1.44
11.30
0.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
0.08
--
0.04
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

47.02

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
47.02
-224.65
35.82
84.23
--
Peer Median
--
5.87
13.03
1.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

27

Lower than Peers by 2,94,223

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
27
--
--
--
91
Peer Median
2,94,251
18
12,900
9
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month